UNICA IRIS Institutional Research Information System

LUPIA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.652
NA - Nord America 148
AS - Asia 35
AF - Africa 1
Totale 13.836
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.625
US - Stati Uniti d'America 147
SG - Singapore 23
DE - Germania 16
CN - Cina 9
GB - Regno Unito 9
IN - India 2
CA - Canada 1
CI - Costa d'Avorio 1
HK - Hong Kong 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 13.836
Salva come PNG Salva come JPEG
Città #
Cagliari 12.139
Uta 1.429
Boardman 84
Ashburn 39
Singapore 13
Washington 7
Los Angeles 6
Milan 6
Krefeld 5
Sassari 5
Islington 3
London 3
Naples 3
Rome 3
Rosignano Marittimo 3
Turin 3
Bad Durrheim 2
Bari 2
Beijing 2
Orotelli 2
Parma 2
Turate 2
Vaishali Nagar 2
Abidjan 1
Council Bluffs 1
Enfield 1
Formia 1
Frankfurt am Main 1
New Bedfont 1
Prescot 1
Santa Clara 1
Santarcangelo di Romagna 1
Smolensk 1
Toronto 1
Wuhan 1
Zhengzhou 1
Totale 13.778
Salva come PNG Salva come JPEG
Nome #
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 996
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 916
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 739
Is there a role for dual PI3K/mTOR inhibitors for patients affected with lymphoma? 730
Current updates on naturally occurring compounds recognizing sars-cov-2 druggable targets 697
In silico food-drug interaction: A case study of eluxadoline and fatty meal 674
Inside perspective of the synthetic and computational toolbox of JAK inhibitors: Recent updates 652
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 626
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 589
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders 575
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators 574
Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 562
Computer-based techniques for lead identification and optimization II: Advanced search methods 561
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 538
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 526
Peptide platform as a powerful tool in the fight against covid-19 516
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 479
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 477
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 460
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 417
Computer-based techniques for lead identification and optimization i: Basics 394
Identification of Compounds Targeting HuD. Another Brick in the Wall of Neurodegenerative Disease Treatment 281
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 263
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 173
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 153
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 139
A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancers 70
Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors 68
New Structural Features of Isatin Dihydrothiazole Hybrids for Selective Carbonic Anhydrase Inhibitors 62
Totale 13.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.734
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234.313 0 0 0 0 0 13 5 0 31 53 73 4.138
2023/20245.499 1.027 131 156 311 374 756 717 524 221 387 524 371
2024/20254.095 927 1.314 1.389 465 0 0 0 0 0 0 0 0
Totale 13.907